分類: ACN Newswire

香港, 2024年12月2日 – (亞太商訊 via SeaPRwire.com) – […]…

一邦攜手義務工作發展局推出「滲漏糾紛義務網上調解服務」

香港, 2024年12月3日 – (亞太商訊 via SeaPRwire.com) – […]…

#CTS24 Concluded Last Week, Advancing Net-Zero Goals and Sustainable Solutions

London, UK, Dec 2, 2024 – (ACN Newswire via SeaPR […]

eBRAM Partners with Agency for Volunteer Service to Launch ‘Pro-Bono Online Mediation Scheme for Water Seepage Disputes’

HONG KONG,Dec 3, 2024 – (ACN Newswire via SeaPRwi […]

康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利

深圳, 2024年12月2日 – (亞太商訊 via SeaPRwire.com) – […]…

15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands

SAN DIEGO, CA, Dec 3, 2024 – (ACN Newswire via Se […]

Advancing the Belt and Road Initiative: The Kyrgyz Republic Ministry of Finance’s First Promotional Seminar and Non-Deal Roadshow Successfully Held

HONG KONG, Dec 3, 2024 – (ACN Newswire via SeaPRw […]

共建一帶一路：吉爾吉斯斯坦國家財政部首場推介會暨非交易性路演成功舉行

香港, 2024年12月3日 – (亞太商訊 via SeaPRwire.com) – […]…

Edvantage Group Announces FY2024 Annual Results

Highlights (relevant audited data for the year ended 31 […]

The Hong Kong Institute of Directors Announces Winners

HONG KONG, Nov 29, 2024 – (ACN Newswire via SeaPR […]

Spritzer Clinches 10th Consecutive “Brand of the Year” Award at the World Branding Awards in London

LONDON, Dec 2, 2024 – (ACN Newswire via SeaPRwire […]

Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong

SHANGHAI, Dec 2, 2024 – (ACN Newswire via SeaPRwi […]

雲頂新耀宣佈中國香港衛生署正式受理伊曲莫德（VELSIPITY(R)）

上海, 2024年12月2日 – (亞太商訊 via SeaPRwire.com) – […]…

Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate

SHANGHAI, Nov 30, 2024 – (ACN Newswire via SeaPRw […]

Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC

SHANGHAI, Nov 30, 2024 – (ACN Newswire via SeaPRw […]

華領醫藥宣佈成功完成在美國開展的第二代葡萄糖激酶激活劑I期臨床研究

香港, 2024年11月30日 – (亞太商訊 via SeaPRwire.com) &#8211 […]…

華領醫藥宣佈成功完成在中國香港開展的SENSITIZE研究